FARGEM, the R&D body of Ulkar Holding, serves the entire group with the research and development activities required by all its branches; pharmaceutical formulation, drug synthesis, pharmacology and pharmacokinetics, analytical research, quality assurance, clinical studies, and documentation. Fargem has been established in 2002 and is in the growth period. Today, with a staff of about 50 highly qualified scientists and technicians, Fargem continues its worldwide search for experienced as well as for young and enthusiastic people who want to start a career in the sector. Within a few years, Fargem will move to a modern center and serve the sector as the first independent R&D institute, which has been projected on 6400 sqm area in the periphery of Istanbul.